Mr. Slump has 4 prior medical device company exits ranging $100M to $800M. He was most recently CEO/Co-Founder of Atraverse Medical acquired in 2026 by J&J for $185M. Previously, Mr. Slump served as CFO/Co-Founder of Attune Medical acquired in 2024 by Haemonetics for $160M. Prior to that, he served as CFO of SIA acquired in 2022 by Integra for ~$100M. Mr. Slump was also the Co-founder of Farapulse acquired in 2021 by Boston Scientific for $800M.

Mr. Garcia is an engineer with +25 years of experience leading multidisciplinary R&D teams in the medical device industry with roles at J&J, Atraverse (1099), and YorLabs. Specializing in EP catheter development, he's led novel products from concept through FDA clearance, translating complex clinical needs into practical engineering solutions & driving innovation that enhances patient outcomes, product performance, and manufacturing excellence.

Dr. Hauserman is a physician-scientist and medtech operator with nearly a decade of experience taking cardiac and surgical technologies from bench to clinic. He has led development, regulatory, and clinical work across three device companies, Most recently, he spearheaded a $3.67M Fast-Track SBIR program advancing a first-in-class non-viral gene therapy for atrial fibrillation, where he has developed deep cardiac EP expertise the last 5+ years.